Beth Israel Deaconess Med. Ctr., ACTG CRS — Boston, Massachusetts

Beth Israel Deaconess Med. Ctr., ACTG CRS is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Med. Ctr., ACTG CRS has participated in 46 clinical trials.

Therapeutic areas: HIV Infections, Sexually Transmitted Diseases, Peripheral Nervous System Disease.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Med. Ctr., ACTG CRS?

Beth Israel Deaconess Med. Ctr., ACTG CRS has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Med. Ctr., ACTG CRS conducted?

Beth Israel Deaconess Med. Ctr., ACTG CRS has 46 clinical trials on record. Their work covers HIV Infections, Sexually Transmitted Diseases, Peripheral Nervous System Disease.

Is Beth Israel Deaconess Med. Ctr., ACTG CRS accredited by Crixeo Health?

Yes — Beth Israel Deaconess Med. Ctr., ACTG CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Beth Israel Deaconess Med. Ctr., ACTG CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.